Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

2.

The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.

Gouzoulis-Mayfrank E, Daumann J.

J Psychopharmacol. 2006 Mar;20(2):188-93. Review.

PMID:
16510477
3.

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.

Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.

J Psychopharmacol. 2006 Mar;20(2):211-25. Review.

PMID:
16510479
4.

Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity.

Parrott AC.

Pharmacol Biochem Behav. 2002 Apr;71(4):837-44. Review.

PMID:
11888574
5.
6.

Ecstasy (MDMA): a review of its possible persistent psychological effects.

Morgan MJ.

Psychopharmacology (Berl). 2000 Oct;152(3):230-48. Review.

PMID:
11105933
7.

Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users.

Parrott AC, Milani RM, Gouzoulis-Mayfrank E, Daumann J.

J Neural Transm (Vienna). 2007;114(8):959-68. Epub 2007 May 24. Review.

PMID:
17520319
8.

MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users.

Parrott AC.

Neurosci Biobehav Rev. 2013 Sep;37(8):1466-84. doi: 10.1016/j.neubiorev.2013.04.016. Epub 2013 May 6. Review.

PMID:
23660456
9.

The harmful health effects of recreational ecstasy: a systematic review of observational evidence.

Rogers G, Elston J, Garside R, Roome C, Taylor R, Younger P, Zawada A, Somerville M.

Health Technol Assess. 2009 Jan;13(6):iii-iv, ix-xii, 1-315. doi: 10.3310/hta13050. Review.

10.

Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy.

Parrott AC.

J Psychopharmacol. 2005 Jan;19(1):71-83. Review.

PMID:
15671132
11.
12.

MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.

Clemens KJ, McGregor IS, Hunt GE, Cornish JL.

Drug Alcohol Rev. 2007 Jan;26(1):9-15. Review.

PMID:
17364831
13.

MDMA: interactions with other psychoactive drugs.

Mohamed WM, Ben Hamida S, Cassel JC, de Vasconcelos AP, Jones BC.

Pharmacol Biochem Behav. 2011 Oct;99(4):759-74. doi: 10.1016/j.pbb.2011.06.032. Epub 2011 Jul 5. Review.

PMID:
21756931
14.
15.

Ecstasy: are animal data consistent between species and can they translate to humans?

Easton N, Marsden CA.

J Psychopharmacol. 2006 Mar;20(2):194-210. Review.

PMID:
16510478
16.

Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects.

Reneman L, de Win MM, van den Brink W, Booij J, den Heeten GJ.

J Psychopharmacol. 2006 Mar;20(2):164-75. Review.

PMID:
16510475
17.

MDMA, cortisol, and heightened stress in recreational ecstasy users.

Parrott AC, Montgomery C, Wetherell MA, Downey LA, Stough C, Scholey AB.

Behav Pharmacol. 2014 Sep;25(5-6):458-72. doi: 10.1097/FBP.0000000000000060. Review.

PMID:
25014666
18.

MDMA and temperature: a review of the thermal effects of 'Ecstasy' in humans.

Parrott AC.

Drug Alcohol Depend. 2012 Feb 1;121(1-2):1-9. doi: 10.1016/j.drugalcdep.2011.08.012. Epub 2011 Sep 15. Review.

PMID:
21924843
19.

[Psychiatric and cognitive long-term effects of ecstasy].

Høiseth G, Løvåsdal Ø, Titze TK, Bramness JG, Bachs L.

Tidsskr Nor Laegeforen. 2006 Feb 23;126(5):596-8. Review. Norwegian.

20.

Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research.

Parrott AC.

Hum Psychopharmacol. 2013 Jul;28(4):289-307. doi: 10.1002/hup.2318. Review.

PMID:
23881877

Supplemental Content

Support Center